Hasil Pencarian - Andreas-Claudius Hoffmann

  • Menampilkan 1 - 5 hasil dari 5
Perbaiki Hasil
  1. 1
    Circulating Tumor Cell Composition in Renal Cell Carcinoma.

    Circulating Tumor Cell Composition in Renal Cell Carcinoma. oleh Ivonne Nel, Thomas C Gauler, Kira Bublitz, Lazaros Lazaridis, André Goergens, Bernd Giebel, Martin Schuler, Andreas-Claudius Hoffmann

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma.

    EGFR, FLT1 and heparanase as markers identifying patients at risk of short survival in cholangiocarcinoma. oleh Andreas-Claudius Hoffmann, Eray Goekkurt, Peter V Danenberg, Sylvia Lehmann, Gerhard Ehninger, Daniela E Aust, Jan Stoehlmacher-Williams

    Diterbitkan 2013-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).

    Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC). oleh Patrick Weller, Ivonne Nel, Philipp Hassenkamp, Thomas Gauler, Anke Schlueter, Stephan Lang, Paulette Dountsop, Andreas-Claudius Hoffmann, Götz Lehnerdt

    Diterbitkan 2014-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy

    MDR1 and ERCC1 Expression Predict Outcome of Patients with Locally Advanced Bladder Cancer Receiving Adjuvant Chemotherapy oleh Andreas-Claudius Hoffmann, Peter Wild, Christina Leicht, Simone Bertz, Kathleen D. Danenberg, Peter V. Danenberg, Robert Stöhr, Michael Stöckle, Jan Lehmann, Martin Schuler, Arndt Hartmann

    Diterbitkan 2010-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF

    High Expression of HIF1a Is a Predictor of Clinical Outcome in Patients with Pancreatic Ductal Adenocarcinomas and Correlated to PDGFA, VEGF, and bFGF oleh Andreas-Claudius Hoffmann, Ryutaro Mori, Daniel Vallbohmer, Jan Brabender, Ellen Klein, Uta Drebber, Stephan E. Baldus, Janine Cooc, Mizutomo Azuma, Ralf Metzger, Arnulf H. Hoelscher, Kathleen D. Danenberg, Klaus L Prenzel, Peter V. Danenberg

    Diterbitkan 2008-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: